Titre:
  • TOP2A protein by quantitative immunofluorescence as a predictor of response to epirubicin in the neoadjuvant treatment of breast cancer.
Auteur:Moretti, Erica; Desmedt, Christine; Biagioni, Chiara; Regan, Meredith M; Oakman, Catherine; Larsimont, Denis; Galardi, Francesca; Piccart-Gebhart, Martine; Sotiriou, Christos; Rimm, David L; Di Leo, Angelo
Informations sur la publication:Future oncology, 9, 10, page (1477-1487)
Statut de publication:Publié, 2013-10
Sujet CREF:Cancérologie
Médecine pathologie humaine
Sciences bio-médicales et agricoles
Mots-clés:anthracyclines
biomarker
breast cancer
quantitative immunofluorescence
TOP2A
MeSH keywords:Antigens, Neoplasm -- genetics -- metabolism
Antineoplastic Agents -- therapeutic use
Breast Neoplasms -- drug therapy -- metabolism -- mortality
Cell Nucleus -- metabolism
Cytoplasm -- metabolism
DNA Topoisomerases, Type II -- genetics -- metabolism
DNA-Binding Proteins -- genetics -- metabolism
Epirubicin -- therapeutic use
Female
Humans
Immunohistochemistry
Neoadjuvant Therapy
Prognosis
Protein Transport
Topoisomerase II Inhibitors -- therapeutic use
Note générale:Journal Article
Research Support, Non-U.S. Gov't
SCOPUS: ar.j
Langue:Anglais
Identificateurs:urn:issn:1479-6694
info:doi/10.2217/fon.13.103
info:scp/84885635917
info:pmid/24106899